Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Danshen dripping pills for stable exertional angina
ChiCTR-IPR-17012014Phase 4Recruiting
- Sponsor
- Tianjin University of Traditional Chinese Medicine
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Compound Danshen and aspirin in angina pectoris and coronary arteriosclerosis (2 arms), sponsored by Tianjin University of Traditional Chinese Medicine. Primary endpoints: Symptoms, Physical signs and 1 more. Started Nov 2017; status: recruiting.
02
Drugs
Compound Danshenaspirin
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-17012014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012014.